CURE is empowered by a strong Board of Directors who collectively bring many years of industry and academic experience to our organization. There have been several important developments regarding the Board in recent weeks.

After many years of effective leadership, David Keiser has elected to retire from his position as co-chair. We thank him for his years of service and wish him all the best in his future endeavors. At the same time, we welcome current board member Stan Choy to his new position as co-chair. Good luck, Stan; we look forward to working with you in your new capacity.

Earlier this month, Andrew Zehner was unanimously elected to the CURE Board of Directors. Andrew is currently at the University of Connecticut, where he serves as Associate Vice President for Research, Technology Commercialization and Industry Relations; and as Counsel for business transactions in the Office of the General Counsel. Welcome, Andrew! (biography).

Best,
Susan
Susan Froshauer, PhD
President and CEO
Connecticut United for Research Excellence, Inc.